Peter Grimison is a medical oncologist from Chris O`Brien Lifehouse cancer hospital and The University of Sydney and is leading the research team for the NSW Government’s clinical trial into the role of cannabis-derived medicines in chemotherapy-induced nausea and vomiting.
Peter Grimison is currently Staff Specialist in Medical Oncology at the Chris O'Brien Lifehouse in Sydney; Visiting Medical Officer at Royal Prince Alfred and Dubbo Base Hospitals; and Clinical Associate Professor at the University of Sydney.
His clinical work focuses on testicular cancer, other genito-urinary cancers, and upper gastro-intestinal cancers. He is involved as germ cell subcommittee chair, member of the scientific advisory committee, trial management committee member, and site principal investigator in several national and international trials for the Australian and New Zealand Urogenital and Prostate Cancer Trials Group, whose coordinating centre is based at the NHMRC Clinical Trials Centre of the University of Sydney. He is also involved as an active member and site Principal Investigator in clinical trials for the Australasian Gastro-Intestinal Trials Group; and site Principal Investigator for industry sponsors. He serves as a member of the Australian Government Pharmaceutical Benefits Advisory Committee, and a number of other Federal and NSW Government committees. He is also committed to teaching as coordinator of Advanced Training in Medical Oncology at the Chris O'Brien Lifehouse, and also actively teaches in Basic Physician Training and the University of Sydney Medical Program.